Moderna, Inc. vs STMicroelectronics NV — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while STMicroelectronics NV trades at $65.7 (market cap $55.80B). The key difference: STMicroelectronics NV is far larger — about 2.4× Moderna, Inc.'s market cap, and STMicroelectronics NV pays a 0.58% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | STM | |
|---|---|---|
Market Cap | $23.60B | $55.80B |
Sector | Health | Financials |
52-Week High | $81.80 | $79.91 |
52-Week Low | $22.36 | $21.20 |
Enterprise Value | $19.70B | $54.01B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →